# clm_B9BD4A691253

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: operating_income  
value: 2,534,400,000 United States dollar  
valid_from: 2018-12-31  
valid_to: 2019-12-31  
published: 2019-02-07  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_1E47F3A48E8B  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals operating income: 2,534,400,000 United States dollar", as of 2018-12-31 (until 2019-12-31). Claim clm_B9BD4A691253, https://asof.is/claim/clm_B9BD4A691253, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217619000009/0001532176-19-000009-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-K FY2018, filed 2019-02-07  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217619000009/0001532176-19-000009-index.htm (primary, SEC EDGAR 10-K FY2018, published 2019-02-07)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 2,079,591,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_B9BD4A691253](/claim/clm_B9BD4A691253.md) | [clm_C3B4B1FC7983](/claim/clm_C3B4B1FC7983.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.